Di Zhao

机构：The University of Texas MD Anderson Cancer Center, Wuhan Polytechnic University, Jilin University, Fudan University, University of Jinan, First Hospital of Jilin University, Zhongshan Hospital · ORCID：0000-0001-6253-7127

发表论文 198 篇 · 总被引 6800 次 · h-index 32

代表论文

• Bimetallic metal organic frameworks-based nanozyme for colorimetry/fluorescence dual-mode uremic toxin detection (2024 · Sensors and Actuators B Chemical · 被引 24)
• In vivo CRISPR activation screen identifies acyl-CoA–binding protein as a driver of bone metastasis (2025 · Science Translational Medicine · 被引 15)
• CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors (2025 · Nature Cancer · 被引 13)
• Histone methyltransferase ASH1L primes metastases and metabolic reprogramming of macrophages in the bone niche (2025 · Nature Communications · 被引 12)
• Comprehensive genomic analysis of type VI secretion system diversity and associated proteins in Serratia (2025 · Microbial Genomics · 被引 4)
• Gusongan capsule enhances osteogenic differentiation to mitigate bone loss in ovariectomized rats via the TLR2/NF-κB pathway (2025 · Phytomedicine · 被引 2)